CD274 and neoplasm: The largest benefit of combination therapy was observed in the subgroup with PD-L1 negative tumors, highlighting the potential of radiotherapy to enhance responses to ICI in immunologically cold (i.e., low tumor mutational burden, low baseline immune cell infiltrate) tumors [11].